Impact of Clinical Pharmacist Intervention in the Intensive Care Unit, Wad Medani, Sudan: A Cross-Sectional, Prospective Study.

IF 2.1 Q3 PHARMACOLOGY & PHARMACY
Integrated Pharmacy Research and Practice Pub Date : 2024-05-09 eCollection Date: 2024-01-01 DOI:10.2147/IPRP.S459170
Yousif B Hamadalneel, Hifa O Ahmed
{"title":"Impact of Clinical Pharmacist Intervention in the Intensive Care Unit, Wad Medani, Sudan: A Cross-Sectional, Prospective Study.","authors":"Yousif B Hamadalneel, Hifa O Ahmed","doi":"10.2147/IPRP.S459170","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Critical care pharmacists are uniquely qualified to provide a key role within the critical care multi-disciplinary team in managing the aspect of therapy, given their contributions to improved patient outcomes, medication safety, and reduced cost of the drug. Therefore, the purpose of this study was to assess the frequency, type, and impact of clinical pharmacist interventions in the Intensive Care Unit and their physicians' acceptance.</p><p><strong>Methods: </strong>This was a cross-sectional, prospective study. Data were gathered over six months (15th June 2023 to 15th December 2023) on a daily basis, with a minimum sample size of 384 interventions. All patients admitted to the ICU at Wad Medani Teaching Hospital, Gezira State, Sudan during the study period were included.</p><p><strong>Results: </strong>In general, a total of 510 interventions were made for 123 patients throughout the six months course of study. Among them, 493 (96.7%) clinical pharmacist interventions were agreed by physicians. Among categories of interventions, most of the recommendations were concerned about safety 34.11% (174/510), in which drug discontinuation due to long duration was the highest one 48.27% (48/174) followed by the renal dose adjustment 30.46% (53/174). Another clinical intervention involving indication accounted for 23.33% (119/510) in second place. Regarding the cost-saving interventions the study showed that, of the total number of interventions, 124 had a costrelated component, accounting for (24.31%) of the total interventions. Among all the interventions, the addition of drug, with a frequency of 103 (20.2%) was the most recurring intervention, followed by dosing at 100 (19.6%), and renal dose adjustment at 53 (10.4%).</p><p><strong>Conclusion: </strong>This study demonstrated how clinical pharmacists might enhance critical care patients' quality management while reducing the costs associated with medication and care. In addition, it contributes valuable insights into the integration of clinical pharmacists in ICU settings, especially in resource-limited environments.</p>","PeriodicalId":45655,"journal":{"name":"Integrated Pharmacy Research and Practice","volume":null,"pages":null},"PeriodicalIF":2.1000,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11090122/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Integrated Pharmacy Research and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/IPRP.S459170","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Critical care pharmacists are uniquely qualified to provide a key role within the critical care multi-disciplinary team in managing the aspect of therapy, given their contributions to improved patient outcomes, medication safety, and reduced cost of the drug. Therefore, the purpose of this study was to assess the frequency, type, and impact of clinical pharmacist interventions in the Intensive Care Unit and their physicians' acceptance.

Methods: This was a cross-sectional, prospective study. Data were gathered over six months (15th June 2023 to 15th December 2023) on a daily basis, with a minimum sample size of 384 interventions. All patients admitted to the ICU at Wad Medani Teaching Hospital, Gezira State, Sudan during the study period were included.

Results: In general, a total of 510 interventions were made for 123 patients throughout the six months course of study. Among them, 493 (96.7%) clinical pharmacist interventions were agreed by physicians. Among categories of interventions, most of the recommendations were concerned about safety 34.11% (174/510), in which drug discontinuation due to long duration was the highest one 48.27% (48/174) followed by the renal dose adjustment 30.46% (53/174). Another clinical intervention involving indication accounted for 23.33% (119/510) in second place. Regarding the cost-saving interventions the study showed that, of the total number of interventions, 124 had a costrelated component, accounting for (24.31%) of the total interventions. Among all the interventions, the addition of drug, with a frequency of 103 (20.2%) was the most recurring intervention, followed by dosing at 100 (19.6%), and renal dose adjustment at 53 (10.4%).

Conclusion: This study demonstrated how clinical pharmacists might enhance critical care patients' quality management while reducing the costs associated with medication and care. In addition, it contributes valuable insights into the integration of clinical pharmacists in ICU settings, especially in resource-limited environments.

临床药剂师干预对苏丹 Wad Medani 重症监护室的影响:一项横断面前瞻性研究。
目的:鉴于重症监护药剂师在改善患者预后、用药安全和降低用药成本方面的贡献,他们在重症监护多学科团队管理治疗方面发挥着独特的作用。因此,本研究旨在评估重症监护病房临床药师干预的频率、类型和影响以及医生的接受程度:这是一项横断面前瞻性研究。数据收集时间为六个月(2023 年 6 月 15 日至 2023 年 12 月 15 日),每天收集一次,最少样本量为 384 次干预。研究期间,苏丹杰济拉州瓦德迈达尼教学医院重症监护室收治的所有患者均被纳入研究范围:总体而言,在为期六个月的研究过程中,共对 123 名患者进行了 510 次干预。其中,493 次(96.7%)临床药师干预得到了医生的同意。在干预类别中,大部分建议涉及安全性,占 34.11%(174/510),其中因用药时间过长而停药的建议最多,占 48.27%(48/174),其次是调整肾脏剂量,占 30.46%(53/174)。另一项涉及适应症的临床干预占 23.33%(119/510),排在第二位。关于节约成本的干预措施,研究显示,在所有干预措施中,有 124 项与成本有关,占干预措施总数的 24.31%。在所有干预措施中,添加药物的频率最高,为 103 次(20.2%),其次是剂量,为 100 次(19.6%),肾脏剂量调整为 53 次(10.4%):这项研究展示了临床药剂师如何在降低用药和护理相关成本的同时,加强危重症患者的质量管理。此外,该研究还为临床药师融入重症监护病房(尤其是在资源有限的环境中)提供了宝贵的见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
3.40%
发文量
29
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信